Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Sign Up to like & getrecommendations! Published in 2020 at "Neural Regeneration Research"
DOI: 10.4103/1673-5374.284981
Abstract: Nafamostat mesylate, an apparent soi-disant panacea of sorts, is widely used to anticoagulate patients undergoing hemodialysis or cardiopulmonary bypass, mitigate the inflammatory response in patients diagnosed with acute pancreatitis, and reverse the coagulopathy of patients… read more here.
Keywords: neuroprotective effects; ischemia nafamostat; nafamostat mesylate; mesylate ... See more keywords